Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

RNA polymerase 2 inhibitor

DRUG CLASS:

RNA polymerase 2 inhibitor

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

KIT positive	Myelodysplastic Syndrome	KIT positive	Myelodysplastic Syndrome	MGTA-117 Sensitive: C3 – Early Trials MGTA-117 Sensitive : C3	MGTA-117 Sensitive: C3 – Early Trials MGTA-117 Sensitive : C3
KIT positive	Acute Myelogenous Leukemia	KIT positive	Acute Myelogenous Leukemia	MGTA-117 Sensitive: C3 – Early Trials MGTA-117 Sensitive : C3	MGTA-117 Sensitive: C3 – Early Trials MGTA-117 Sensitive : C3
KIT expression	Leukemia	KIT expression	Leukemia	MGTA-117 Sensitive: D – Preclinical MGTA-117 Sensitive : D	MGTA-117 Sensitive: D – Preclinical MGTA-117 Sensitive : D
KIT expression	Acute Myelogenous Leukemia	KIT expression	Acute Myelogenous Leukemia	MGTA-117 Sensitive: D – Preclinical MGTA-117 Sensitive : D	MGTA-117 Sensitive: D – Preclinical MGTA-117 Sensitive : D
PTPRC expression	Leukemia	PTPRC expression	Leukemia	CD45-ADC Sensitive: D – Preclinical CD45-ADC Sensitive : D	CD45-ADC Sensitive: D – Preclinical CD45-ADC Sensitive : D
TNFRSF17 expression	Multiple Myeloma	TNFRSF17 expression	Multiple Myeloma	HDP-101 Sensitive: D – Preclinical HDP-101 Sensitive : D	HDP-101 Sensitive: D – Preclinical HDP-101 Sensitive : D